0001157523-19-001608.txt : 20190729 0001157523-19-001608.hdr.sgml : 20190729 20190729160017 ACCESSION NUMBER: 0001157523-19-001608 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190729 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190729 DATE AS OF CHANGE: 20190729 FILER: COMPANY DATA: COMPANY CONFORMED NAME: COGNEX CORP CENTRAL INDEX KEY: 0000851205 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 042713778 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34218 FILM NUMBER: 19981161 BUSINESS ADDRESS: STREET 1: ONE VISION DR CITY: NATICK STATE: MA ZIP: 01760 BUSINESS PHONE: 5086503000 MAIL ADDRESS: STREET 1: ONE VISION DRIVE CITY: NATICK STATE: MA ZIP: 01760 8-K 1 a52020429.htm COGNEX CORPORATION 8-K
 
UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 
Date of report (Date of earliest event reported): July 29, 2019

Cognex Corporation

(Exact name of registrant as specified in charter)
 
Massachusetts
 001-34218
04-2713778
 (State or other jurisdiction
of incorporation)
 (Commission
File Number)
 (IRS Employer
Identification No.)

One Vision Drive, Natick, Massachusetts
01760-2059
 (Address of principal executive offices)
(Zip Code)


Registrant's telephone number, including area code: (508) 650-3000

N/A

(Former name or former address, if changed since last report.)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $.002 per share
CGNX
The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 

Item 2.02          Results of Operations and Financial Condition

On July 29, 2019, Cognex Corporation (the “Company”) issued a news release to report its financial results for the quarter ended June 30, 2019. The release is furnished as Exhibit 99.1 hereto. The information in Item 2.02 of this Current Report on Form 8-K, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, regardless of any general incorporation language in such filing.

Item 8.01          Other Events

On July 29, 2019, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.05 per share. This dividend is payable on August 30, 2019 to all shareholders of record at the close of business on August 16, 2019.

Item 9.01          Financial Statements and Exhibits

(d)            Exhibits

Exhibit No.              Description

99.1                          News release, dated July 29, 2019, by Cognex Corporation

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
COGNEX CORPORATION
 
 
Dated: July 29, 2019
By:/s/ Laura A. MacDonald
 
Laura A. MacDonald
 
Vice President and Corporate Controller

EX-99.1 2 a52020429ex99_1.htm EXHIBIT 99.1
Exhibit 99.1


Cognex Reports Results for the Second Quarter Of 2019

NATICK, Mass.--(BUSINESS WIRE)--July 29, 2019--Cognex Corporation (NASDAQ: CGNX) today announced financial results for the second quarter of 2019. Table 1 below shows selected financial data for Q2-19 compared with Q2-18 and Q1-19, and for the six months ended June 30, 2019 compared with the same period in 2018.

Table 1

(Dollars in thousands, except per share amounts)


 

 

 

 

Revenue

 

 

 

Net Income

 

Net Income
per Diluted
Share

Non-GAAP
Net Income

per Diluted
Share*

Quarterly Comparisons

 

 

 

 

Current quarter: Q2-19

$199,047

$48,749

$0.28

$0.27

Prior year’s quarter: Q2-18

$211,264

$56,196

$0.32

$0.31

Change: Q2-18 to Q2-19

(6%)

(13%)

(13%)

(13%)

Prior quarter: Q1-19

$173,484

$33,104

$0.19

$0.17

Change: Q1-19 to Q2-19

15%

47%

47%

59%

Year-to-Date Comparisons

 

 

 

 

Six months ended June 30, 2019

$372,531

$81,853

$0.47

$0.44

Six months ended July 1, 2018

$380,831

$93,413

$0.52

$0.49

Change from first six months of 2018 to first six months of 2019

(2%)

(12%)

(10%)

(10%)

*Non-GAAP net income per diluted share excludes tax adjustments. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.


“Our Q2 results were in line with our guidance and we were highly profitable, reporting an operating margin of 26%,” said Dr. Robert J. Shillman, Founder and Chairman of Cognex. “But, as expected, revenue declined year over year due to persistent softness in our two largest markets, consumer electronics and automotive.”

“Despite continued strong growth in logistics, the slowdown in spending by customers in our two largest markets resulted in lower overall revenue for Cognex,” said Robert J. Willett, Chief Executive Officer of Cognex. “Because of that slowdown we have reallocated resources to faster-growing areas.”

“Our long-term positive view notwithstanding, our outlook for the near term has worsened due to a further deterioration in business conditions we are seeing in Europe and Asia,” concluded Mr. Willett.

Details of the Quarter

Statement of Operations Highlights – Second Quarter of 2019

  • Revenue decreased 6% from Q2-18 and increased 15% from Q1-19. The year-on-year decline in revenue was expected and reflects lower sales to customers in consumer electronics and automotive. The decrease was partially offset by continued growth in logistics. The sequential increase in revenue was due to higher revenue from logistics and the usual seasonal increase in sales to customers in the consumer electronics market. In constant currency, revenue decreased 3% year-on-year and increased 15% sequentially.
  • Gross margin was 74% for Q2-19 compared with 74% for Q2-18 and 73% for Q1-19. Gross margin increased on a sequential basis primarily due to revenue mix.
  • Research, Development & Engineering (RD&E) expenses increased 4% from Q2-18 and decreased 7% from Q1-19. The year-on-year increase in RD&E reflects the addition of new Cognex engineering resources over the past year. The increase was partially offset by a reduction in incentive compensation costs. The sequential decrease in RD&E is due to the timing of application engineering for large deployments in consumer electronics. In constant currency, RD&E increased 6% year-on-year and decreased 7% sequentially.
  • Selling, General & Administrative (SG&A) expenses increased 2% from both Q2-18 and Q1-19. The year-on-year and sequential increases in SG&A are a result of Cognex growing its sales and support organization. The increase year-on-year was partially offset by a reduction in incentive compensation costs and lower costs incurred related to the company’s new ERP system, which was placed into service in mid-2018. In constant currency, SG&A increased 5% year-on-year and 3% sequentially.
  • The effective tax rate was 14% in Q2-19, 16% in Q2-18, and 7% in Q1-19. Excluding discrete tax adjustments, the rates were 17%, 17%, and 15%, respectively (tax adjustments are summarized in Exhibit 2). The tax rate for 2019 was adjusted in Q2-19 to reflect the expectation that more of the company’s 2019 profits will be earned and taxed in higher-tax jurisdictions than anticipated.

Balance Sheet Highlights – June 30, 2019

  • Cognex’s financial position as of June 30, 2019, continued to be very strong, with $862 million in cash and investments and no debt. In the first six months of 2019, Cognex generated $120 million in cash from operations, spent $62 million to repurchase its common stock, and paid out $17 million in dividends paid to shareholders. Cognex intends to continue to repurchase shares of its common stock, subject to market conditions and other relevant factors.

Financial Outlook – Q3 2019

  • Revenue for Q3-19 is expected to be between $175 million and $185 million, which represents a decline from both Q3-18 and Q2-19. The decline from Q3-18 is due almost entirely to lower expected revenue from consumer electronics. The decline from Q2-19 is due to typical seasonal softness experienced during Q3, outside of consumer electronics, and increased weakness expected in Europe and Asia.
  • Gross margin is expected to be in the mid-70% range, slightly lower than the gross margin reported for Q2-19.
  • Cognex expects operating expenses to be relatively flat on a sequential basis.
  • The effective tax rate is expected to be 16% before discrete tax items.

Non-GAAP Financial Measures

  • Exhibit 2 of this news release includes a reconciliation of certain financial measures from GAAP to non-GAAP. Cognex believes these non-GAAP financial measures are helpful because they allow investors to more accurately compare Cognex results over multiple periods using the same methodology that management employs in its budgeting process and in its review of Cognex’s operating results. Non-GAAP presentations exclude the following: (1) stock option expense for calculating non-GAAP adjusted operating income and net income from continuing operations (because these expenses have no current effect on cash or the future uses of cash, and they fluctuate because of changes in Cognex’s stock price), and (2) certain one-time discrete events, such as tax adjustments(because these costs are outside of Cognex’s normal business operations). Cognex also uses results on a constant-currency basis as one measure to evaluate performance. Constant-currency information compares results between periods as if the exchange rates had remained constant period-over-period. Cognex does not intend for non-GAAP financial measures to be considered in isolation, or as a substitute for financial information provided in accordance with GAAP.
  • The tax effect of items identified in the reconciliation is estimated by applying the effective tax rate to the pre-tax amount. However, if a specific tax rate or tax treatment is required because of the nature of the item and/or the tax jurisdiction where the item was recorded, the tax effect is estimated by applying the relevant specific tax rate or tax treatment, rather than the effective tax rate.

Analyst Conference Call and Simultaneous Webcast

  • Cognex will host a conference call today at 5:00 p.m. Eastern Daylight Time (EDT). The telephone number is (877) 704-4573 (or (201) 389-0911 if outside the United States). A replay will begin at 8:00 p.m. EDT today and will be available until 11:59 p.m. EDT on Thursday, August 1, 2019. The telephone number for the replay is (877) 660-6853 (or (201) 612-7415 if outside the United States). The access code for both the live call and the replay is 13691043.
  • A real-time audio broadcast of the conference call or an archived recording will be accessible on the Events & Presentations page of the Cognex Investor website: http://www.cognex.com/Investor.

About Cognex Corporation

Cognex Corporation designs, develops, manufactures and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.

Cognex is the world's leader in the machine vision industry, having shipped more than 2 million image-based products, representing over $6 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe and Asia. For details visit Cognex online at www.cognex.com.

Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These forward-looking statements, which include statements regarding business and market trends, future financial performance, customer order rates and the timing of related revenue, expected areas of growth, emerging markets, future product mix, research and development activities, investments, strategic plans, and stock repurchases, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include: (1) the loss of a large customer; (2) current and future conditions in the global economy, including the imposition of tariffs or export controls; (3) the reliance on revenue from the consumer electronics or automotive industries; (4) the inability to penetrate new markets; (5) the inability to achieve significant international revenue; (6) fluctuations in foreign currency exchange rates and the use of derivative instruments; (7) information security breaches or business system disruptions; (8) the inability to attract and retain skilled employees; (9) the failure to effectively manage our growth; (10) the reliance upon key suppliers to manufacture and deliver critical components for our products; (11) the failure to effectively manage product transitions or accurately forecast customer demand; (12) the inability to design and manufacture high-quality products; (13) the technological obsolescence of current products and the inability to develop new products; (14) the failure to properly manage the distribution of products and services; (15) the inability to protect our proprietary technology and intellectual property; (16) our involvement in time-consuming and costly litigation; (17) the impact of competitive pressures; (18) the challenges in integrating and achieving expected results from acquired businesses; (19) potential impairment charges with respect to our investments or for acquired intangible assets or goodwill; (20) exposure to additional tax liabilities; and (21) the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2018. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.


 

Exhibit 1

COGNEX CORPORATION
Statements of Operations
(Unaudited)
Dollars in thousands, except per share amounts




 

 

Three-months Ended

 

Six-months Ended

 

June 30, 2019

 

March 31, 2019

 

July 1, 2018

 

June 30, 2019

 

July 1, 2018

 

 

 

 

 

 

 

 

 

 

Revenue

$

199,047

 

 

$

173,484

 

 

$

211,264

 

 

$

372,531

 

 

$

380,831

 

Cost of revenue (1)

50,967

 

 

46,284

 

 

54,169

 

 

97,251

 

 

94,367

 

Gross margin

148,080

 

 

127,200

 

 

157,095

 

 

275,280

 

 

286,464

 

Percentage of revenue

74

%

 

73

%

 

74

%

 

74

%

 

75

%

Research, development, and engineering expenses (1)

28,079

 

 

30,242

 

 

26,888

 

 

58,321

 

 

57,964

 

Percentage of revenue

14

%

 

17

%

 

13

%

 

16

%

 

15

%

Selling, general, and administrative expenses (1)

68,245

 

 

66,811

 

 

66,752

 

 

135,056

 

 

130,449

 

Percentage of revenue

34

%

 

39

%

 

32

%

 

36

%

 

34

%

Operating income

51,756

 

 

30,147

 

 

63,455

 

 

81,903

 

 

98,051

 

Percentage of revenue

26

%

 

17

%

 

30

%

 

22

%

 

26

%

Foreign currency gain (loss)

140

 

 

(248

)

 

(195

)

 

(108

)

 

(329

)

Investment and other income

5,079

 

 

5,832

 

 

3,313

 

 

10,911

 

 

6,830

 

Income before income tax expense

56,975

 

 

35,731

 

 

66,573

 

 

92,706

 

 

104,552

 

Income tax expense

8,226

 

 

2,627

 

 

10,377

 

 

10,853

 

 

11,139

 

Net income

$

48,749

 

 

$

33,104

 

 

$

56,196

 

 

$

81,853

 

 

$

93,413

 

Percentage of revenue

24

%

 

19

%

 

27

%

 

22

%

 

25

%

 

 

 

 

 

 

 

 

 

 

Net income per weighted-average common and common-equivalent share:

 

 

 

 

 

 

 

 

 

Basic

$

0.28

 

 

$

0.19

 

 

$

0.33

 

 

$

0.48

 

 

$

0.54

 

Diluted

$

0.28

 

 

$

0.19

 

 

$

0.32

 

 

$

0.47

 

 

$

0.52

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common and common-equivalent shares outstanding:

 

 

 

 

 

 

 

 

 

Basic

171,318

 

 

171,098

 

 

172,370

 

 

171,209

 

 

172,825

 

Diluted

175,448

 

 

175,607

 

 

177,149

 

 

175,528

 

 

178,418

 

 

 

 

 

 

 

 

 

 

 

Cash dividends per common share

$

0.050

 

 

$

0.050

 

 

$

0.045

 

 

$

0.100

 

 

$

0.090

 

Cash and investments per common share

$

5.05

 

 

$

5.03

 

 

$

4.39

 

 

$

5.05

 

 

$

4.39

 

Book value per common share

$

6.98

 

 

$

6.93

 

 

$

6.27

 

 

$

6.98

 

 

$

6.27

 

 

 

 

 

 

 

 

 

 

 

(1) Amounts include stock option expense, as follows:

 

 

 

 

 

 

 

 

 

Cost of revenue

$

329

 

 

$

451

 

 

$

557

 

 

$

780

 

 

$

1,354

 

Research, development, and engineering

3,550

 

 

4,467

 

 

3,154

 

 

8,017

 

 

7,969

 

Selling, general, and administrative

7,088

 

 

7,363

 

 

5,291

 

 

14,451

 

 

12,873

 

Total stock option expense

$

10,967

 

 

$

12,281

 

 

$

9,002

 

 

$

23,248

 

 

$

22,196

 


Exhibit 2

COGNEX CORPORATION
Reconciliation of Selected Items from GAAP to Non-GAAP
(Unaudited)
Dollars in thousands, except per share amounts





 

 

Three-months Ended

 

 

Six-months Ended

 

June 30, 2019

 

March 31, 2019

 

July 1, 2018

 

 

June 30, 2019

 

July 1, 2018

Adjustment for stock option expense and tax benefit for stock option exercises

 

 

 

 

 

 

 

Operating income (GAAP)

$

51,756

 

 

$

30,147

 

 

$

63,455

 

 

 

$

81,903

 

 

$

98,051

 

Stock option expense

10,967

 

 

12,281

 

 

9,002

 

 

 

23,248

 

 

22,196

 

Operating income (Non-GAAP)

$

62,723

 

 

$

42,428

 

 

$

72,457

 

 

 

$

105,151

 

 

$

120,247

 

Percentage of revenue (Non-GAAP)

32

%

 

24

%

 

34

%

 

 

28

%

 

32

%

 

 

 

 

 

 

 

 

 

 

 

 

Net income (GAAP)

$

48,749

 

 

$

33,104

 

 

$

56,196

 

 

 

$

81,853

 

 

$

93,413

 

Stock option expense

10,967

 

 

12,281

 

 

9,002

 

 

 

23,248

 

 

22,196

 

Tax effect on stock option expense

(1,813

)

 

(2,222

)

 

(1,607

)

 

 

(4,035

)

 

(3,954

)

Discrete tax benefit related to employee stock options

(1,248

)

 

(2,730

)

 

(654

)

 

 

(3,978

)

 

(5,589

)

Net income (Non-GAAP)

$

56,655

 

 

$

40,433

 

 

$

62,937

 

 

 

$

97,088

 

 

$

106,066

 

Percentage of revenue (Non-GAAP)

28

%

 

23

%

 

30

%

 

 

26

%

 

28

%

 

 

 

 

 

 

 

 

 

 

 

Net income per diluted weighted-average common and common-equivalent share (GAAP)

$

0.28

 

 

$

0.19

 

 

$

0.32

 

 

 

$

0.47

 

 

$

0.52

 

Per share impact of non-GAAP adjustments identified above

0.04

 

 

0.04

 

 

0.04

 

 

 

0.08

 

 

0.07

 

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.32

 

 

$

0.23

 

 

$

0.36

 

 

 

$

0.55

 

 

$

0.59

 

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted-average common and common-equivalent shares outstanding (GAAP)

175,448

 

 

175,607

 

 

177,149

 

 

 

175,528

 

 

178,418

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exclusion of tax adjustments

 

 

 

 

 

 

 

 

 

 

Income before income tax expense (GAAP)

$

56,975

 

 

$

35,731

 

 

$

66,573

 

 

 

$

92,706

 

 

$

104,552

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense (GAAP)

$

8,226

 

 

$

2,627

 

 

$

10,377

 

 

 

$

10,853

 

 

$

11,139

 

Effective tax rate (GAAP)

14

%

 

7

%

 

16

%

 

 

12

%

 

11

%

 

 

 

 

 

 

 

 

 

 

 

Tax adjustments:

 

 

 

 

 

 

 

 

 

 

Discrete tax benefit related to employee stock options

1,248

 

 

2,730

 

 

654

 

 

 

3,978

 

 

5,589

 

Other discrete tax events

 

 

3

 

 

 

 

 

3

 

 

 

Income tax expense excluding tax adjustments (Non-GAAP)

$

9,474

 

 

$

5,360

 

 

$

11,031

 

 

 

$

14,834

 

 

$

16,728

 

Effective tax rate (Non-GAAP)

17

%

 

15

%

 

17

%

 

 

16

%

 

16

%

 

 

 

 

 

 

 

 

 

 

 

 

Net income excluding tax adjustments (Non-GAAP)

$

47,501

 

 

$

30,371

 

 

$

55,542

 

 

 

$

77,872

 

 

$

87,824

 

Percentage of revenue (Non-GAAP)

24

%

 

18

%

 

26

%

 

 

21

%

 

23

%

 

 

 

 

 

 

 

 

 

 

 

 

Net income per diluted weighted-average common and common-equivalent share (GAAP)

$

0.28

 

 

$

0.19

 

 

$

0.32

 

 

 

$

0.47

 

 

$

0.52

 

Per share impact of non-GAAP adjustments identified above

(0.01

)

 

(0.02

)

 

(0.01

)

 

 

(0.03

)

 

(0.03

)

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.27

 

 

$

0.17

 

 

$

0.31

 

 

 

$

0.44

 

 

$

0.49

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted-average common and common-equivalent shares outstanding (GAAP)

175,448

 

 

175,607

 

 

177,149

 

 

 

175,528

 

 

178,418

 

 


 

 

 



 





Exhibit 3

COGNEX CORPORATION
Balance Sheets
(Unaudited)
Dollars in thousands







 

 




June 30, 2019

 

December 31, 2018

Assets




 

 

 

Cash and investments




$

861,623

 

 

$

797,599

 

Accounts receivable




107,643

 

 

119,172

 

Unbilled revenue




10,300

 

 

8,312

 

Inventories




72,889

 

 

83,282

 

Property, plant, and equipment




89,342

 

 

91,396

 

Operating lease assets




17,928

 

 

 

Goodwill and intangible assets




121,783

 

 

123,321

 

Other assets




68,412

 

 

66,585

 

 




 

 

 

Total assets




$

1,349,920

 

 

$

1,289,667

 

 




 

 

 

Liabilities and Shareholders' Equity




 

 

 

Accounts payable and accrued expenses




$

60,438

 

 

$

76,450

 

Operating lease liabilities




17,984

 

 

 

Deferred revenue and customer deposits




18,332

 

 

9,845

 

Income taxes




60,282

 

 

64,243

 

Other liabilities




1,244

 

 

3,866

 

Shareholders' equity




1,191,640

 

 

1,135,263

 

 




 

 

 

Total liabilities and shareholders' equity




$

1,349,920

 

 

$

1,289,667

 

 

Contacts

Susan Conway
Senior Director of Investor Relations
Cognex Corporation
Phone: (508) 650-3353
Email: susan.conway@cognex.com